*Corresponding author:
Norbert Klein, Department of Cardiology, Angiology and Internal Intensive Medicine, St. Georg Hospital Leipzig, GermanyReceived: September 4, 2018; Published: September 10, 2018
DOI: 10.26717/BJSTR.2018.08.001716
To view the Full Article Peer-reviewed Article PDF
Background: Neuropeptides can be influenced by psychophysical stress and may have influence on cardiac function. Objective: We wanted to find out, whether pro- and anti-inflammatory neuropeptides may be altered in heart failure (HF) and may be modulated by psychophysical stress.
Methods: Therefore, 29 patients of both gender suffering form heart failure (NYHA II-III) or and 20 healthy volunteers were investigated for the levels of the pro-inflammatory neuropeptides TNFα, IL-6, IL-2, IL-1β and IL-12, and of the anti-inflammatory neuropeptides GHrelin, urocortin, adrenomedullin and VIP as well as for TH1, TH2, TH17, CD4 and CD4CD25 cells. Left ventricular (LV) ejection fraction (LVEF), end-diastolic and end-systolic diameter (LVEDD; LVESD) were assessed echocardiographically. Psychophysical stress and quality of life was evaluated by the SF-36 questionnaire.
Results: In NYHA II- and III-patients urocortin, adrenomedullin and VIP were elevated, while Ghrelin, TNFα, IL-12 and IL-2 were unchanged. IL-6 was slightly elevated and IL-1β was slightly reduced in NYHA II. TH17 cells were reduced, while TH1, TH2 and CD4 were unchanged. CD4CD25 were slightly increased. SF-36 questionnaire revealed nearly unchanged emotional and social functioning while the physical role functioning was reduced in HF-patients.
Conclusion: HF is associated with reduced quality of life as concerning physical role functioning, reduced ventricular performance and alterations of the balance between pro- and anti-inflammatory neuropeptides so that pro-inflammatory TH17 cells are reduced. Since neuropeptides also can affect cardiac output, these results indicate the activation of a neuropeptide-heart axis in HF, yet unknown. Socio-emotional stress does not seem to account for the changes.
Declaration: there is no conflict of interest of any author with any third party to declare.
Keywords: Neuropeptides; Adrenomedullin; Phenotyping Kit; Heart Failure; Hyperthyreosis; Amyloidosis; Gravidity; Implantation; Left Ventricular; Quality of Life
Abstract | Introduction | Methods | Results | Discussion | References |
International Association of Landscape Archaeology, Czech Glass Society, Czech Republic
Department of Chemistry, Semenov Institute of Chemical Physics, USSR Academy of Sciences, Moscow, Russia
Pharmaco-kinetics, dynamics and Drug Metabolism, Touro College of Pharmacy, USA
Professor of Nuclear Medicine, Faculty of Medicine and Surgery, University of Milan, Milan, Italy
Associate Professor at Department of Breast and Thyorid Surgey, Chongqing General Hospital, China